Precision Oncology Market – Long-Term Industry Outlook to 2032
The market includes genomic profiling, biomarker testing, liquid biopsy, companion diagnostics, next-generation sequencing (NGS), targeted therapies, immunotherapies, and data-driven treatment selection. Precision oncology enables clinicians to select more individualized treatment strategies and reduce reliance on therapies that may prove less effective for specific patient populations.